Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehmet Sofuoglu

Showing results (1-10 of 197) with videos related to

Pageof 20
Sort By:
Addiction (Abingdon, England)|January 18, 2012
Commentary on Ling et al. (2012): The PROMETA™ treatment does not reduce methamphetamine useMehmet Sofuoglu
Addiction (Abingdon, England)|January 19, 2010
Cognitive enhancement as a pharmacotherapy target for stimulant addictionMehmet Sofuoglu
Current Neuropharmacology|November 8, 2017
Cognitive Effects of Nicotine: Recent ProgressGerald Valentine, Mehmet Sofuoglu
CNS Drugs|October 23, 2009
Cholinergic functioning in stimulant addiction: implications for medications developmentMehmet Sofuoglu, Marc Mooney
Experimental and Clinical Psychopharmacology|April 1, 2009
Subjective responses to intravenous nicotine: greater sensitivity in women than in menMehmet Sofuoglu, Marc Mooney
British Journal of Clinical Pharmacology|October 9, 2012
Future pharmacological treatments for substance use disordersAriadna Forray, Mehmet Sofuoglu
Addiction Biology|September 25, 2008
Norepinephrine and stimulant addictionMehmet Sofuoglu, R Andrew Sewell
Addiction Biology|May 12, 2010
Cognitive effects of nicotine: genetic moderatorsAryeh I Herman, Mehmet Sofuoglu
The American Journal on Addictions|April 12, 2011
Effects of galantamine on cocaine use in chronic cocaine usersMehmet Sofuoglu, Kathleen M Carroll
Psychiatric Research and Clinical Practice|September 14, 2022
The Opioid Crisis: Filling in the PictureKimberly A Yonkers, Mehmet Sofuoglu
Pageof 20

Showing results (1-10 of 197) with videos related to

Sort By:
Pageof 20
Addiction (Abingdon, England)|January 18, 2012
Commentary on Ling et al. (2012): The PROMETA™ treatment does not reduce methamphetamine useMehmet Sofuoglu
Addiction (Abingdon, England)|January 19, 2010
Cognitive enhancement as a pharmacotherapy target for stimulant addictionMehmet Sofuoglu
Current Neuropharmacology|November 8, 2017
Cognitive Effects of Nicotine: Recent ProgressGerald Valentine, Mehmet Sofuoglu
CNS Drugs|October 23, 2009
Cholinergic functioning in stimulant addiction: implications for medications developmentMehmet Sofuoglu, Marc Mooney
Experimental and Clinical Psychopharmacology|April 1, 2009
Subjective responses to intravenous nicotine: greater sensitivity in women than in menMehmet Sofuoglu, Marc Mooney
British Journal of Clinical Pharmacology|October 9, 2012
Future pharmacological treatments for substance use disordersAriadna Forray, Mehmet Sofuoglu
Addiction Biology|September 25, 2008
Norepinephrine and stimulant addictionMehmet Sofuoglu, R Andrew Sewell
Addiction Biology|May 12, 2010
Cognitive effects of nicotine: genetic moderatorsAryeh I Herman, Mehmet Sofuoglu
The American Journal on Addictions|April 12, 2011
Effects of galantamine on cocaine use in chronic cocaine usersMehmet Sofuoglu, Kathleen M Carroll
Psychiatric Research and Clinical Practice|September 14, 2022
The Opioid Crisis: Filling in the PictureKimberly A Yonkers, Mehmet Sofuoglu
Pageof 20